Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies - Additional Information (Details)

v3.22.1
Summary of Significant Accounting Policies - Additional Information (Details)
 12 Months Ended
Aug. 11, 2021
$ / shares
shares
Jan. 06, 2021
USD ($)
$ / shares
shares
Jan. 03, 2020
shares
Dec. 31, 2021
USD ($)
item
Dec. 31, 2020
USD ($)
item
Restricted cash       $ 45,000 $ 45,000
Goodwill       0 3,484,607
Impairment loss       4,498,234 0
In-process R&D       8,696,000 9,730,000
Impairment loss of in-process R&D       1,770,314 0
Deferred Tax Liabilities, Net       614,436 728,926
Unrecognized uncertain income tax       0 0
Money Market Funds Fair Value       6,519,000 5,343,000
Fair value of contingent consideration       0 0
Other assets or liabilities that are subject to fair value methodology and estimation       $ 0 $ 0
Number of vendors with whom the company has entered into related party transactions | item       1 2
Number of consultants with whom the company has entered into related party transactions | item       6 7
Shares issued | shares 4,668,844 1,531,101 500,000    
Warrants to purchase common stock | shares 233,442        
Accumulated Deficit       $ (124,733,753) $ (108,338,834)
Purchase price | $ / shares $ 2.3025        
Net proceeds from the private placement   $ 8,000,000.0      
Related party transactions payments related to services provided         502,000
Contingent consideration liability       29,719 0
Common Stock | Private Placement          
Shares issued | shares   1,531,101      
Warrants to purchase common stock | shares   1,531,101      
Purchase price | $ / shares   $ 5.225      
Net proceeds from the private placement       $ 8,000,000.0  
Maximum [Member]          
Estimated useful life (in years)       5 years  
Minimum [Member]          
Estimated useful life (in years)       2 years  
Panoptes acquisition          
Contingent consideration liability       $ 212,000  
Contingent consideration         $ 3,633,000
Bayon acquisition          
Contingent consideration       $ 1,388,000